June 4-8, 2021; Online at https://conferences.asco.org/am
In the randomized TOTEM trial, intensive follow-up did not improve overall survival, relapse-free survival, or health-related quality-of-life outcomes vs minimalist follow-up in patients treated for endometrial cancer.